Lauren Schaeffer
Family · Beaumont, TXNPI 1609508084
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 328 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 27.8% of the total. 2025 is the largest year on record at $2,740, 7.0 times the $391 reported in 2022. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 328 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Sanofi$711
- UCB, Inc.$439
- Regeneron Healthcare Solutions, Inc.$277
- Galderma Laboratories, L.p.$253
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,49996%
- Education$2414%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 104 | $1,872 |
| Johnson & Johnson | 51 | $1,523 |
| Sanofi | 33 | $711 |
| UCB, Inc. | 14 | $439 |
| Regeneron Healthcare Solutions, Inc. | 10 | $277 |
| Galderma Laboratories, L.p. | 25 | $253 |
| Sun Pharmaceutical Industries Inc. | 5 | $237 |
| Novartis | 10 | $177 |
| Amgen | 8 | $163 |
| E.r. Squibb & Sons, L.L.C. | 8 | $149 |
| Organon | 17 | $131 |
| Boehringer Ingelheim | 7 | $127 |
| Arcutis Biotherapeutics, Inc. | 6 | $114 |
| Incyte Corporation | 4 | $105 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $85 |
| Almirall LLC | 3 | $51 |
| Lilly USA, LLC | 2 | $47 |
| Dermavant Sciences, Inc. | 2 | $44 |
| Pfizer | 2 | $34 |
| Sandoz | 2 | $34 |
| LEO Pharma Inc. | 2 | $33 |
| Botanix SB Inc | 2 | $33 |
| Verrica Pharmaceuticals Inc. | 2 | $32 |
| Krystal Biotech Inc | 1 | $23 |
| Genentech USA, Inc. | 1 | $19 |
| LNHC, Inc | 1 | $15 |
| Kerecis Limited | 1 | $13 |
How this compares
$6,741 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $70,983 |
Paid to pharmacies, not to this prescriber.
Other family in Beaumont
- Daisy ArcoBeaumont$30K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.